retatrutide peptide side effects long term Retatrutide Side Effects: What We Know So Far Retatrutide for weight loss: Study

Weve been working in the NHS since 2017, supporting people to lose weight and manage their type 2 diabetes

Ozempic contains semaglutide and is approved for type 2 diabetes, while Wegovy contains semaglutide and is approved for chronic weight management

In clinical trials, people taking Contrave lost an average of approximately 8.1% of their total body weight over 56 weeks at the maximum dose

Contrave specifically mentions the risk in children, adolescents, and young adults, while Wegovy advises monitoring for depression and suicidal thoughts in all individuals

In one study, people who took Semaglutide GLP-1 injections along with making lifestyle changes lost an average of 15.3% of their initial body weight over 68 weeks